Friday, April 24, 2020 2:55:09 PM
04/24/2020 9 Entry of appearance for Eric Sonnenschein as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689729] [20-1723] [Eric Sonnenschein] [Entered: 04/24/2020 10:53 AM]
04/24/2020 10 Entry of appearance for Jeffrey Elikan as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689737] [20-1723] [Jeffrey Elikan] [Entered: 04/24/2020 11:05 AM]
04/24/2020 11 Entry of appearance for Christopher Sipes as of counsel for Appellant Amarin Pharma, Inc.. Service: 04/24/2020 by email. [689739] [20-1723] [Christopher Sipes] [Entered: 04/24/2020 11:10 AM]
04/24/2020 12 Entry of appearance for Charles B. Klein as principal counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689797] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:45 PM]
04/24/2020 13 Docketing Statement for the Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689800] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:49 PM]
04/24/2020 14 Certificate of Interest for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689803] [20-1723] [Charles Klein] [Entered: 04/24/2020 12:51 PM]
04/24/2020 15 Entry of appearance for Claire A. Fundakowski as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689805] [20-1723] [Claire Fundakowski] [Entered: 04/24/2020 12:53 PM]
04/24/2020 16 Entry of appearance for Alison M. Heydorn as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689809] [20-1723] [Alison Heydorn] [Entered: 04/24/2020 12:57 PM]
04/24/2020 17 Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellees West-Ward Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.. Service: 04/24/2020 by email. [689811] [20-1723] [Eimeric Reig-Plessis] [Entered: 04/24/2020 12:59 PM]
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM